Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1864663 (
HCC
)
2,985
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The function of
FAM9C
encoding a testis-exclusively expressed and nuclear-localized protein remains unknown. In the present study, we evaluated the role of
FAM9C
in human hepatocellular carcinoma. We found that among three FAM9 family members, only
FAM9C
was frequently upregulated in
HCC
specimens compared with that in corresponding adjacent non-cancer liver tissues.
FAM9C
was located in the nucleus of
HCC
cells, as shown by both western blotting and immumofluorescence assays. Significantly,
FAM9C
overexpression promoted proliferation, clonogenicity in an anchorage-dependent manner, in vivo tumorigenicity of YY-8103, and Huh-7 cells. In contrast,
FAM9C
knockdown suppressed proliferation, anchorage-dependent colony formation and in vivo tumorigenicity of QGY-7703, and BEL-7404 cells. However,
FAM9C
had no significant effects on cell cycle progression when
FAM9C
was stably overexpressed in Huh-7 cells or knocked down in BEL-7404 cells. Most importantly,
FAM9C
regulated activation of Akt and UV-induced apoptosis in
HCC
cells.
FAM9C
overexpression increased the phosphorylation levels of Akt and anti-apoptotic ability of Huh-7 cells, whereas endogenous
FAM9C
knockdown reduced the phosphorylated levels of Akt and anti-apoptotic ability of BEL-7404 cells. Furthermore, the anti-apoptotic function of
FAM9C
could be prevented when the PI3K-Akt pathway was in a loss-of-function caused by RNA interference against Akt or PI3K inhibitor LY294002 in
HCC
cells. Taken together, our data demonstrate that
FAM9C
as a novel cancer testis gene plays an anti-apoptotic role in human hepatocellular carcinoma through activating the PI3K/Akt signaling pathway, and serves as a promising target for
HCC
therapy.
...
PMID:FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma. 2383 95